Tags : OR2805

Just – Evotec Signs a Development and Manufacturing Agreement with

Shots: Just-Evotec to leverage its technology platform, J.Design to accelerate OncoResponse’s OR2805 through the development and into the clinic Just-Evotec provides services to the OncoResponse which includes cell line development, process development, and P-I/II cGMP clinical manufacturing of OR2805 in human clinical studies OncoResponse’s OR2805 is an Ab, reversing the immunosuppression in the tumor microenvironment […]Read More